TerraVia

San Francisco, United States Founded: 2003 • Age: 23 yrs Listed Acquired By Corbion
Algae-based specialty ingredients are manufactured and supplied for food applications.

About TerraVia

TerraVia is a Healthcare company based in San Francisco (United States) founded in 2003, and was acquired by Corbion in September 2017. It operates as an algae-based specialty ingredients are manufactured and supplied for food applications. It operates in the Healthcare and Agriculture sectors. TerraVia has raised $60 million across 6 funding rounds from investors including Morgan Stanley, Corbion and Unilever. The company was acqui-hired. Its focus areas include Food and Agriculture Tech, Aquaculture Tech, Aquatic Plants and Algae. Its competitors include Enzymotec, Microphyt, Advanced Enzyme Technologies, Fermentalg and Simris Alg and 3 more; 7 of its 8 listed competitors have raised funding.

Company details

TerraVia was founded in 2003 in San Francisco, United States, and operates in the biotechnology and food ingredients sector. Algae-derived specialty ingredients are produced through an industrial fermentation process that converts natural sugars into oils, proteins, fats, fibers, and micronutrients. These components are supplied for nutritional food applications, with production methods avoiding genetically engineered algae. Operations emphasize sustainable practices in ingredient development and distribution.

  • Headquarters San Francisco, United States
  • Stage Public
  • Sectors
    Healthcare
    Agriculture
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website terravia.com
  • Social LinkedIn X
  • Acquired by Corbion (Sep 2017)
Key Metrics

Funding Insights of TerraVia

TerraVia has successfully raised a total of $60M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $60M
  • Total Rounds 6
  • First Round $5M

    (Sep 2007)

  • Investors Count 17

All 6 funding rounds of TerraVia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2016–Post-IPO––
Mar 2016$28MPost-IPO––
Sep 2010$60MSeries D––
Dec 2009$21.8MGrant––
Sep 2007$2MGrant––
Sep 2007$5MDebt – Venture––
Valuation history

18 investors in total: 18 institutional.

Investors in TerraVia

TerraVia has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include Morgan Stanley, Corbion and Unilever.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Multi-sector company acquisitions are managed by VMG Partners.
–vmgpartners.comSan Francisco, United States
Offline focused VC firm funding companies in the US
–powerplantvc.comHermosa Beach, United States
Venture capital fund focused on multiple sectors
–simonequity.comLarkspur, United States
Early-stage startups are invested in by Artis Ventures.
–av.coSan Francisco, United States
Investments are made in US expansion-stage energy and tech companies.
–braemarenergy.comNew York, United States
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
1997lsvp.comMenlo Park, United States
Seed and early-stage venture capital is provided in the US.
–rodagroup.comBerkeley, United States
Venture capital firm
–vpcp.comSanta Barbara, United States
Zygote Ventures is engaged in seed and angel investments.
2013zygoteventures.comBerkeley, United States
VC firm funding companies in the US
1981180degreecapital.comMontclair, United States
Premium access

Investor details for TerraVia

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of TerraVia

5 dated milestones of TerraVia across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded TerraVia is founded.
  2. Funding First funding round of $5.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO,.
  5. Exit Acquired by Corbion.

Competitors of TerraVia

TerraVia has 8 listed competitors in our database, 7 of them funded. They include Enzymotec, Microphyt, Advanced Enzyme Technologies, Fermentalg and Simris Alg, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enzymotec.com1998Kfar Saba, Israel$21M–
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses.
microphyt.eu2007Baillargues, France$18.08M–
Microalgae cultivation technology is developed and supplied.
advancedenzymes.com1989Thane, India–689
Enzymes are manufactured for nutrition, food, feed, and textile industries.
fermentalg.com2005Libourne, France$30.3M–
Microalgae are processed via fermentors to yield biomass feedstock.
simrisalg.se2009Hammenhog, Sweden$7.79M–
Algae are cultivated, harvested, and processed into oils and products.
algaia.com2010Brest, France$7.09M–
Seaweed-based biological solutions for agriculture and beyond are developed.
danisco.com1989Copenhagen, Denmark$880,0851,007
Manufactures a range of health ingredients
zarbees.com2008Draper, United States$28.28M–
Natural cough remedies and wellness products are developed by Zarbees.
Premium access

Detailed competitors of TerraVia

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

10 companies that operate in the same segment as TerraVia (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 27.35 M362
Plant-based frozen meals are delivered via weekly subscriptions.
2016London, England, United KingdomUSD 69.9 MUSD 12.54 M146
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M–910
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M––
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M––
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M––
Cellular health supplements for metabolic repair are developed and manufactured.
2014New York, New York, United StatesUSD 66.1 M––
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 23.98 M–
Low-carb products for weight loss are provided by Atkins.
1960Denver, Colorado, United StatesUSD 15 M––
Synbiotic supplements and fermented products for gut health are provided.
2021Mumbai, Maharashtra, IndiaUSD 20.02 MUSD 5.14 M88
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Terravia

Premium access

Complete news archive for TerraVia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about TerraVia

TerraVia was founded in 2003 and raised its 1st funding round 4 years after it was founded.

TerraVia is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

TerraVia is a funded company, having raised a total of $60M across 6 funding rounds to date. The company's 1st funding round was a Debt – Venture of $5M, raised on Sep 2007.

TerraVia was founded in 2003 in San Francisco, United States, and operates in the biotechnology and food ingredients sector. Algae-derived specialty ingredients are produced through an industrial fermentation process that converts natural sugars into oils, proteins, fats, fibers, and micronutrients. These components are supplied for nutritional food applications, with production methods avoiding genetically engineered algae. Operations emphasize sustainable practices in ingredient development and distribution.

TerraVia's top competitors include Fermentalg, Microphyt and Advanced Enzyme Technologies.

TerraVia has 18 investors. Key investors include Morgan Stanley, Corbion, Unilever, Lightspeed Venture Partners, and Bunge.

Yes. TerraVia was acquired by Corbion in September 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available